FlixBus
Private Equity Round in 2024
FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.
IntegrityNext
Venture Round in 2023
IntegrityNext is a Munich-based company founded in 2016 by Martin Berr-Sorokin that specializes in supply chain compliance and sustainability monitoring. The company offers a cloud-based platform that enables businesses to oversee their suppliers' compliance with regulatory requirements, thereby reducing risk. Its platform automates the collection of supplier self-assessments and certificates, while also monitoring social media for potential malpractice and reputational threats. With features such as automated risk alerts, a pre-built supplier questionnaire, and a real-time dashboard, IntegrityNext assists small and medium-sized enterprises in translating complex compliance data requirements from international regulations into effective processes and systems. This comprehensive approach to supply chain compliance supports organizations in achieving greater transparency and accountability in their operations.
va-Q-tec
Acquisition in 2023
va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.
Cardiac Dimensions
Series D in 2023
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.
Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.
Cardior Pharmaceuticals
Series B in 2021
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, founded in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a critical microRNA responsible for pathological changes in the heart resulting from stress or injury. Through its innovative approach, Cardior Pharmaceuticals seeks to address significant unmet medical needs in cardiovascular health.
Onward
Venture Round in 2021
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
Cardiac Dimensions
Series C in 2020
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.
Deutsche Glasfaser
Acquisition in 2020
Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks aimed at rural and suburban areas. As a pioneering provider in the industry, the company focuses on delivering fiber-to-the-home (FTTH) connections to private households, businesses, and public institutions. By collaborating closely with municipalities, Deutsche Glasfaser aims to facilitate nationwide broadband expansion, contributing significantly to Germany's digital progress. The company is recognized for its innovative and cost-efficient approaches to fiber optic deployment, positioning itself as a technology leader in the market. With substantial backing from experienced investors, Deutsche Glasfaser has emerged as one of the strongest providers in Germany's telecommunications landscape.
Mabtech
Debt Financing in 2019
Mabtech AB is a biotech company based in Stockholm, Sweden, specializing in the development and manufacture of monoclonal antibodies and diagnostic kits. Founded in 1986, the company offers a range of products for enzyme-linked immuno sorbent assay (ELISA), enzyme-linked immunospot assay (ELISpot), and FluoroSpot methods, facilitating the detection of cytokines and other immunological molecules. Mabtech's product portfolio includes monoclonal antibodies for various applications, as well as specialized kits for ELISA, ELISpot, and FluoroSpot, which allow for the simultaneous detection of multiple analytes. The company serves a diverse clientele, providing tools for research involving human and animal samples across various species. Mabtech sells its products online and has established locations in the United States, Australia, Germany, and France, operating as a subsidiary of Mabtech Group AB.
Atlantic Therapeutics Limited
Series B in 2019
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
SUSE is a global leader in open source solutions, providing reliable and enterprise-grade software to a diverse range of industries, including automotive, telecom, banking, healthcare, manufacturing, retail, and technology. With a strong focus on Enterprise Linux, Kubernetes Management, and Edge solutions, SUSE supports mission-critical workloads for over 60% of the Fortune 500 companies. The company emphasizes collaboration with partners and communities to empower customers to innovate across various environments, from data centers to the cloud and edge. SUSE offers consulting, blended services, and training and certification, primarily generating revenue from subscriptions. Headquartered in Nuremberg, Germany, SUSE employs nearly 2,000 people globally and derives a significant portion of its revenue from North America.
MediFox
Debt Financing in 2018
MediFox GmbH, founded in 1994 and headquartered in Hildesheim, Niedersachsen, Germany, specializes in developing software solutions for ambulatory nursing care service providers and nursing care homes. The company offers enterprise system software designed to support outpatient care services, inpatient facilities, and therapeutic practices. MediFox's software encompasses essential services such as resource and route planning, care and support documentation, management information systems, and administration services, including billing and factoring. By providing these tools, MediFox enables care providers to enhance their organizational structure and streamline their processes in response to evolving industry needs.
BBS Automation
Private Equity Round in 2018
BBS Automation GmbH is a provider of automation solutions and engineering services, specializing in the design, development, manufacturing, and installation of automated assembly and testing systems. The company serves a diverse range of industries, including automotive, aerospace, life sciences, consumer goods, electronic devices, energy storage, and renewable energy. BBS Automation also offers leak detection, build-to-print services, and winding technology solutions, along with training and after-sales support. With nearly 550 employees, the company operates production sites in Germany, China, Malaysia, and the United States, partnering with prominent global clients. Founded in 1891 and headquartered in Garching bei München, Germany, BBS Automation is committed to delivering flexible and high-quality automation solutions for complex manufacturing and testing processes.
Simplify Medical
Series B in 2018
Simplify Medical, Inc. is a medical device company specializing in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs intended for spinal use. Founded in 2013 and based in Sunnyvale, California, it offers innovative products such as the Simplify Disc, a non-metallic, MRI-compatible artificial cervical disc that preserves motion while allowing for full diagnostic imaging without the need for traditional CT scans. This technology minimizes patient exposure to ionizing radiation and is tailored for skeletally mature patients undergoing reconstruction at one level from C3 to C7 following discectomy procedures. Simplify Medical markets its products through distributors in the United Kingdom, Germany, and other international markets. The company was previously known as Simplify Delaware, Inc. before rebranding in February 2015.
Studienkreis
Venture Round in 2017
Studienkreis is one of Germany's largest providers of professional tutoring services, operating nearly 1,000 tuition schools nationwide since its establishment in 1974. The company specializes in providing offline and digital tutoring aimed at primary and secondary school students, offering support across all major subjects through its proprietary teaching materials and scientifically backed learning methodologies. Studienkreis focuses on helping children and adolescents enhance their academic performance and achieve consistently good grades. In addition to addressing specific academic queries, the company emphasizes fostering independent learning skills and a sense of responsibility in students, thereby improving their overall confidence in their educational journey.
Dentconnect
Acquisition in 2017
DentConnect is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. DentConnect is headquartered in the Netherlands and serves over one million patients through its pan-European network of over 220 clinics. DentConnect acts as a multi-functional service organization for these clinics, allowing the dentists to fully focus on providing patients with the best possible care. DentConnect Shared Service Center supports and facilitates dentists with HR, Finance and administration, quality and care management, procurement, marketing and communication and general management.
Atricom and Le Büro
Private Equity Round in 2017
Two modern and strategically located office buildings in suburban Frankfurt.
Simplify Medical
Series B in 2017
Simplify Medical, Inc. is a medical device company specializing in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs intended for spinal use. Founded in 2013 and based in Sunnyvale, California, it offers innovative products such as the Simplify Disc, a non-metallic, MRI-compatible artificial cervical disc that preserves motion while allowing for full diagnostic imaging without the need for traditional CT scans. This technology minimizes patient exposure to ionizing radiation and is tailored for skeletally mature patients undergoing reconstruction at one level from C3 to C7 following discectomy procedures. Simplify Medical markets its products through distributors in the United Kingdom, Germany, and other international markets. The company was previously known as Simplify Delaware, Inc. before rebranding in February 2015.
Cardior Pharmaceuticals
Series A in 2017
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, founded in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a critical microRNA responsible for pathological changes in the heart resulting from stress or injury. Through its innovative approach, Cardior Pharmaceuticals seeks to address significant unmet medical needs in cardiovascular health.
GETEC is a prominent group of energy service providers operating across Germany and Europe, employing nearly 1,400 individuals. The company offers a comprehensive range of energy services in the liberalized energy market, focusing on energy efficiency, system design, and zero emissions. GETEC aims to guide clients through the complexities of the energy landscape by developing tailored solutions that extend beyond traditional energy considerations. Their approach emphasizes sustainability, efficiency, economic viability, and resource conservation, which are fundamental principles of their corporate philosophy. By providing integrated system solutions, GETEC creates added value for clients and supports them in improving their carbon footprint, with a commitment to future generations.
GlobalConnect
Acquisition in 2016
GlobalConnect is a prominent alternative provider of fiber network, data center, and managed hosting services in Northern Europe, primarily focusing on Denmark and Germany. Established in 1998 by Niels Zibrandtsen, the company operates a 12,500 km optical fiber network and manages approximately 13,000 square meters of data center space. GlobalConnect offers a range of services including bandwidth connectivity, colocation, and cloud infrastructure, catering to both enterprises and consumers. With a workforce of over 200 employees, the company is dedicated to delivering fast and reliable networking solutions, enhancing connectivity and technological capabilities for its clients across Sweden, Norway, Denmark, Finland, and Northern Germany.
GETEC is a prominent group of energy service providers operating across Germany and Europe, employing nearly 1,400 individuals. The company offers a comprehensive range of energy services in the liberalized energy market, focusing on energy efficiency, system design, and zero emissions. GETEC aims to guide clients through the complexities of the energy landscape by developing tailored solutions that extend beyond traditional energy considerations. Their approach emphasizes sustainability, efficiency, economic viability, and resource conservation, which are fundamental principles of their corporate philosophy. By providing integrated system solutions, GETEC creates added value for clients and supports them in improving their carbon footprint, with a commitment to future generations.
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
kfzteile24
Venture Round in 2016
kfzteile24 GmbH, established in 2001 and headquartered in Berlin, Germany, is a prominent retailer of automotive spare parts and accessories. The company operates primarily online via its platforms www.kfzteile24.de and www.autoteile24.de, offering a comprehensive range of products such as exhaust systems, axle suspension components, batteries, heaters, interior fittings, and braking systems at competitive prices. To complement its online distribution, kfzteile24 maintains three physical retail stores in Berlin, each with an affiliated repair shop for customer support. The company has experienced continuous growth since its founding, becoming one of Germany's largest online retailers for auto parts and accessories, with sales in the triple-digit million range.
kfzteile24
Acquisition in 2015
kfzteile24 GmbH, established in 2001 and headquartered in Berlin, Germany, is a prominent retailer of automotive spare parts and accessories. The company operates primarily online via its platforms www.kfzteile24.de and www.autoteile24.de, offering a comprehensive range of products such as exhaust systems, axle suspension components, batteries, heaters, interior fittings, and braking systems at competitive prices. To complement its online distribution, kfzteile24 maintains three physical retail stores in Berlin, each with an affiliated repair shop for customer support. The company has experienced continuous growth since its founding, becoming one of Germany's largest online retailers for auto parts and accessories, with sales in the triple-digit million range.
HusCompagniet
Acquisition in 2015
Founded in 2015, HusCompagniet is a leading Danish company specializing in the development of single-family detached houses. It offers customizable designs primarily built on-site on customer-owned land, and also produces prefabricated wood-framed houses under the VårgårdaHus brand in Sweden. The company is renowned for its high-quality products and great value for money, having been awarded House Builder of the Year in Denmark for three consecutive years.
Cardiac Dimensions
Series A in 2015
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.
Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.
Evidensia Djursjukvård
Acquisition in 2014
Evidensia Djursjukvård AB is a veterinary clinic chain headquartered in Stockholm, Sweden, operating over 180 clinics and hospitals across Sweden, Norway, Denmark, Finland, Germany, Holland, and Switzerland. The company provides a comprehensive range of animal care services, including veterinary care, food, medicine, and supplies for various pets, such as dogs, cats, small animals, exotic animals, and horses. Through its extensive network, Evidensia aims to deliver quality veterinary services to pet owners in multiple countries.
Charleston Holding
Acquisition in 2014
Charleston Holding is an operator of nursing homes and residential care facilities in Germany, focused on serving physically and mentally impaired residents. The company adopts a buy-and-build strategy within the nursing home market, aiming to enhance its portfolio through acquisitions. Charleston provides a range of services, including nursing care, preventative care, and intensive care, along with assisted living and daycare options. By offering these services, Charleston Holding seeks to improve the quality of life for its residents and support their well-being into old age.
EEW Energy from Waste
Acquisition in 2013
Founded in 1873, EEW Energy from Waste designs, builds, and operates waste incineration plants. It generates power and heat from waste, contributing to climate neutrality and resource conservation. The company manages approximately five million tons of waste annually across 37 modern plants, producing electricity for around 500,000 households and steam for industrial use.
Internetstores
Venture Round in 2012
Internetstores GmbH is a German-based company, established in 2003, that operates both online and physical retail stores specializing in bicycles and outdoor products. Its offerings include a wide range of bikes, sportswear, accessories, and outdoor adventure gear, catering to both recreational and hobbyist customers. With a presence in Germany, Sweden, and France, the company maintains retail stores in these countries and has additional offices in Esslingen, Stuttgart, Berlin, Lyon, and Stockholm. As a subsidiary of Signa Retail GmbH, internetstores operates as a multi-store e-commerce platform, serving customers across Europe.
Vivoryon Therapeutics
Venture Round in 2012
Vivoryon Therapeutics is a biopharmaceutical company focused on developing therapeutic products for the treatment of Alzheimer's disease and cancer. Its lead product candidate, PQ912, has completed Phase IIb clinical trials for Alzheimer's disease. The company also has preclinical development products targeting cancer and is exploring monoclonal antibody therapies.
ATOS MEDICAL
Acquisition in 2011
Atos Medical, founded in 1986, specializes in manufacturing therapeutic devices aimed at enhancing the quality of life for laryngectomized patients. The company produces a range of products, including voice prosthetics, pulmonary rehabilitation devices, adhesives, laryngectomy tubes, and hands-free speaking devices. With its headquarters in Sweden, Atos Medical operates a state-of-the-art clean room and laboratory to support research and development. The company has established a significant international presence, with subsidiaries in multiple countries, including the USA, UK, Germany, Spain, the Netherlands, Belgium, Sweden, and Switzerland, along with exclusive distributors in around 60 countries.
Sapiens Steering Brain Stimulation
Series A in 2011
Sapiens Steering Brain Stimulation GmbH is a medical device company focused on advancing deep brain stimulation (DBS) therapy. Founded in 2011 as a spin-out of Royal Philips Electronics, Sapiens operates from offices in Eindhoven, the Netherlands, and Munich, Germany. The company is dedicated to developing a high-resolution, MRI-compatible DBS system designed to enhance patient comfort and improve therapeutic outcomes, particularly for individuals with Parkinson's disease. Sapiens’ innovative approach includes a unique steering brain stimulation system and image-guided programming, both of which are based on patented technologies.
Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.
Activaero
Series A in 2011
Activaero develops controlled breathing technologies for efficient pulmonary delivery of inhaled therapeutics. Its flagship product, AKITA, uses smart card technology to enable safe and precise local drug deposition in the lungs, targeting conditions such as asthma, COPD, cystic fibrosis, and idiopathic pulmonary fibrosis.
AcadeMedia
Acquisition in 2010
AcadeMedia is Northern Europe's largest independent education provider, offering comprehensive educational services ranging from preschool to adult education. It operates approximately 550 units across Sweden, Norway, and Germany.
Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.
Vivoryon Therapeutics
Series B in 2009
Vivoryon Therapeutics is a biopharmaceutical company focused on developing therapeutic products for the treatment of Alzheimer's disease and cancer. Its lead product candidate, PQ912, has completed Phase IIb clinical trials for Alzheimer's disease. The company also has preclinical development products targeting cancer and is exploring monoclonal antibody therapies.
Sausalitos
Private Equity Round in 2008
Founded in Germany in 1994, Sausalitos operates a chain of casual gastro pubs offering a variety of food and drinks, specializing in Californian-Mexican cuisine.
PharmaZell
Debt Financing in 2007
PharmaZell develops and produces pharmaceutical active ingredients (API), offering custom synthesis and finished dosage form development projects. With a global presence and ethical principles, it serves the pharmaceutical industry worldwide, providing reliable solutions since 1947.
Scandic Hotels Group
Acquisition in 2007
Scandic Hotels Group operates over 200 hotels across 120 destinations in seven countries, primarily in the Nordics. The company generates majority of its revenue from business travel and conferences.
CBR Fashion Group
Acquisition in 2007
Based in Isernhagen, Germany, CBR Fashion Group is a manufacturer and distributor of women's apparel. It produces twelve collections annually for each label, offering retail partners swift turnover and adaptability.
Pfaff Beteiligungs GmbH
Acquisition in 2006
Pfaff-silberblau's lifting and material handling business includes wire rope winches, chain hoists, rack and pinion jacks and hand pallet trucks. Its actuator business designs, develops, manufactures and markets components for lifting and motion control, including worm gear screw jacks, linear motion precision screws and quick lifting screw jacks. Based in Kissing, Germany, Pfaff-silberblau employs over 300 people and is represented worldwide through six international subsidiaries as well as numerous regional representatives.
U3 Pharma
Venture Round in 2006
U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the
ground-breaking discoveries made by its founder - Professor Axel Ullrich.
Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.
Metall Technologie Holding
Debt Financing in 2005
Metall Technologie Holding is a German manufacturer specializing in heat treatment industrial furnaces and related technologies. The company produces a variety of furnace types, including vacuum furnaces, continuous furnaces, atmosphere furnaces, and protective gas furnaces. Its products cater to diverse industries such as aeronautics, automotive, medical, steel manufacturing, and heat treatment contracting, serving clients globally. Metall Technologie Holding's furnaces are utilized for a wide range of applications, including gas and oil quenching, brazing of aluminum and stainless steel, sintering, metal injection molding, tempering, annealing, magnetic annealing and stabilization, aging and stress relieving, as well as low-pressure carburizing, nitriding, and cryogenic treatment.
Sportfive (Active Sports Marketing)
Debt Financing in 2004
SPORTFIVE is an international sports marketing agency that operates as a subsidiary of Lagardère SCA, having rebranded from Lagardère Sports UK Limited in May 2020. Established in 1998 and headquartered in Wilmslow, United Kingdom, SPORTFIVE employs approximately 500 individuals across its offices in Europe and Asia. The agency boasts over 25 years of industry experience and is recognized as a leader in sports marketing, particularly in Germany, where it manages marketing rights for numerous top-tier professional football clubs, as well as rights in handball, winter sports, and motorsports. In France, SPORTFIVE collaborates closely with various clubs, federations, and events, while in Africa, it serves as the exclusive marketing and media agent for the Confédération Africaine de Football (CAF). The agency provides a comprehensive range of services, including sponsorship and brand partnerships, athlete management, content creation, and media rights, effectively connecting rights holders, athletes, and brands with diverse opportunities in the sports and entertainment sectors.
Nederman
Acquisition in 1999
Nederman specializes in developing, producing, and marketing solutions to displace or extract hazardous substances such as fumes from industrial workplaces. The company offers a range of products and services designed to measure, control, and clean air, aiming to improve sustainability, safety, and efficiency in industrial production.